Home > Boards > US OTC > Biotechs > Ampio Pharmaceuticals, Inc (AMPE)

The best part is that this news has

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
TJG Member Profile
Member Level 
Followed By 566
Posts 27,551
Boards Moderated 3
Alias Born 06/20/07
160x600 placeholder
Ampio Pharmaceuticals Receives Investigational Review Board Approval for its Phase I Long COVID-19 Trial (AP-018) PR Newswire (US) - 5/10/2021 9:15:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/5/2021 4:12:17 PM
Ampio Pharmaceuticals EPS in-line Seeking Alpha - 5/5/2021 4:09:53 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/5/2021 4:06:45 PM
Ampio Pharmaceuticals, Inc. Reports First Quarter 2021 Financial Results and Provides Business Update PR Newswire (US) - 5/5/2021 4:01:00 PM
Ampio Pharma's Ampion reduces mortality nearly 80% in COVID-19 Seeking Alpha - 4/27/2021 9:36:16 AM
Ampion™ Reduces All-cause Mortality in COVID-19 Respiratory Distress by Nearly 80% PR Newswire (US) - 4/27/2021 9:15:00 AM
Ampio Pharmaceuticals Provides Updates on Clinical Programs for Ampion™ in Osteoarthritis and COVID-19 PR Newswire (US) - 4/27/2021 9:15:00 AM
Ampio Pharmaceuticals, Inc. to Report Fiscal 2021 First Quarter Financial Results and Provide Corporate Business Update PR Newswire (US) - 4/21/2021 9:15:00 AM
Research Shows Ampion™ Gene Regulation Mimics the Anti-Inflammatory Effects of Steroids, but without Adverse Effects PR Newswire (US) - 4/19/2021 9:15:00 AM
Ampio posts encouraging results from Ampion COVID-19 pre-clinical study Seeking Alpha - 4/6/2021 9:30:28 AM
Ampio Pharmaceuticals' Study Shows Ampion Inhibits a Key Inflammatory Pathway in COVID-19 and Lupus Nephritis PR Newswire (US) - 4/6/2021 9:15:00 AM
Ampio Pharmaceuticals to Present at the International Society for Aerosols in Medicine (ISAM) 23rd International Congress PR Newswire (US) - 3/29/2021 9:15:00 AM
Ampio Pharmaceuticals to Present at Benzinga Biotech Small Cap Conference PR Newswire (US) - 3/19/2021 9:15:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/17/2021 6:36:01 PM
Ampio surges 7.5% on phase 1 data for COVID-19 respiratory treatment Seeking Alpha - 3/16/2021 10:01:12 AM
Ampio Pharmaceuticals posts early positive results in inhaled Ampion COVID-19 trial Seeking Alpha - 3/16/2021 9:57:57 AM
Ampio Pharmaceuticals Details Early Positive Results for Inhaled Ampion in COVID-19 Respiratory Distress PR Newswire (US) - 3/16/2021 9:15:00 AM
Ampio Pharmaceuticals to Participate in the 33rd Annual Virtual ROTH Conference on March 15-17, 2021 PR Newswire (US) - 3/10/2021 4:01:00 PM
Ampio Pharmaceuticals EPS in-line Seeking Alpha - 3/3/2021 4:10:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/3/2021 4:06:38 PM
Ampio Pharmaceuticals, Inc. Reports Fourth Quarter 2020 Financial Results and Provides Business Update PR Newswire (US) - 3/3/2021 4:01:00 PM
Ampio Pharmaceuticals to Present at the H.C. Wainwright Global Life Sciences Conference PR Newswire (US) - 3/3/2021 9:15:00 AM
Ampio Pharmaceuticals, Inc. to Report Annual 2020 Financial Results and Provide Corporate Business Update PR Newswire (US) - 2/24/2021 9:15:00 AM
Ampio adds new Ampion COVID-19 trial sites Seeking Alpha - 2/23/2021 9:41:24 AM
TJG Member Level  Wednesday, 11/25/20 09:35:52 AM
Re: TJG post# 910
Post # of 1344 
The best part is that this news has not caused a spike in the pre market trading, and will likely not cause one once the market opens. So every share collected under a dollar is a gift in my opinion. By end of December there should be plenty of reason to celebrate this stock. FDA will comment on the osteoarthritis of the knee (OAK): The amendment to the OAK Phase III clinical trial (AP-013), that harmonizes the FDA agreement on the Special Protocol Assessment (SPA) with FDA guidance for clinical trials on hold due to COVID-19, has been received by the FDA. The FDA notified the Company that a formal response will be provided by the end of this year.

Put that with the results of the next Phase study of the Nebulizer, remember its only a 5 day trial and 3 day follow up for results, so there wont be the usual 6 to 8 months to get results and notification from the FDA on how they view the results.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences